BiotechTube

eszopiclone, zolpidem, placebo

ApprovedWithdrawn
0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Healthy

Conditions

Healthy

Trial Timeline

— → —

NCT ID
NCT00781482

About eszopiclone, zolpidem, placebo

eszopiclone, zolpidem, placebo is a approved stage product being developed by Sumitomo Pharma for Healthy. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT00781482. Target conditions include Healthy.

What happened to similar drugs?

20 of 20 similar drugs in Healthy were approved

Approved (20) Terminated (0) Active (0)
✅Cholestyramine + Colesevelam HClDaiichi SankyoApproved
✅Cholestyramine + Cholestyramine + TangDaiichi SankyoApproved
✅Olmesartan medoxomil + Irbesartan + ValsartanDaiichi SankyoApproved
✅Perampanel 6 MGEisaiApproved
✅Listerine Experimental Mouthwash + Colgate Cavity Protection Toothpaste + Listerine Total Care ZeroJohnson & JohnsonApproved
✅Listerine Clinical Solutions Teeth Strength + Listerine Total Care Zero Alcohol Mouthwash + Colgate Cavity Protection ToothpasteJohnson & JohnsonApproved
✅Colgate Cavity Protection Toothpaste + LISTERINE ZERO Alcohol Mouthwash COOL MINT + LISTERINE COOL MINT Antiseptic MouthwashJohnson & JohnsonApproved

Hype Score Breakdown

Clinical
20
Activity
0
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00781482ApprovedWithdrawn

Competing Products

20 competing products in Healthy

See all competitors
ProductCompanyStageHype Score
AZD0837AstraZenecaPhase 1
29
ValsartanNovartisPhase 1
29
CSL112 + PlaceboCSLPhase 1
29
UT-15CUnited TherapeuticsPhase 1
26
VNA-318 + PlaceboBiotrialPhase 1
19
Open-label TRV734 125 mg + TRV734 blinded + Oxycodone IR 10 mg + PlaceboTrevenaPhase 1
19
TRV130 + Moxifloxacin + PlaceboTrevenaPhase 1
19
Radiolabeled TRV130TrevenaPhase 1
19
TRV130A + Dextrose in WaterTrevenaPhase 1
19
TRV734TrevenaPhase 1
19
ALT02 + EU-licensed Herceptin + US-licensed HerceptinAlteogenPhase 1
29
ENZ215 + EU Sourced Prolia + US Sourced ProliaAlkem LaboratoriesPhase 1
29
KPL-404Kiniksa PharmaceuticalsPhase 1
23
MORF-057 + Placebo for MORF-057Eli LillyPhase 1
29
Propranolol + PseudoephedrineEli LillyPre-clinical
26
LY2157299Eli LillyPhase 1
29
Lasmiditan + PlaceboEli LillyPhase 1
29
LY3015014 + PlaceboEli LillyPhase 1
29
LOXO-783Eli LillyPhase 1
29
LY2541546 - IV + LY2541546 - SC + PlaceboEli LillyPhase 1
29